BPH-703

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBPH-703
Drug Alias Namegeranylgeranyl diphosphate synthase inhibitor (University of Illinois)BPH-703
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIsoprenoid lipid metabolism modulators
TargetsUpdating
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Illinois
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Illinois
Active IndicationsN/A
Inactive IndicationsMalaria

Other Information

ATC CodeN/A
Related LinksN/A